Pillstats
Rx only · Tablet · Oral

Labetalol Hydrochloride

Labetalol Hydrochloride

5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
5 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6185
US makers5 labelers
Packages32
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 18 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.042$0.084$0.127$0.169Dec 2025May 2026Jul 2026
$0.140
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
5
Active US suppliers
53%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

23K45K68K91K2025 Q12025 Q22025 Q32025 Q42026 Q1
63K
Rx · 2026 Q1
6.1M
Units dispensed
-20%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it5 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Epic Pharma, LLCunknown9SUPPLYING
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.unknown8SUPPLYING
NorthStar Rx LLCunknown6SUPPLYING
BluePoint Laboratoriesunknown6SUPPLYING
Chartwell RX, LLCunknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.